检索结果 - Angeline Zhu

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up

    Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up 由 Martin Dreyling, André Goy, Georg Heß, Brad S. Kahl, José‐Ángel Hernández‐Rivas, Natasha Schuier, Keqin Qi, Sanjay Deshpande, Angeline Zhu, Lori Parisi, Michael Wang

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts

    Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts 由 Peter Martin, Jonathon B. Cohen, Michael Wang, Anita Kumar, Brian T. Hill, Diego Villa, Jeffrey M. Switchenko, Brad S. Kahl, Kami J. Maddocks, Natalie S. Grover, Keqin Qi, Lori Parisi, K. Daly, Angeline Zhu, Gilles Salles

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: